Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells

Chenglai Xia(Guangzhou Medical University), Shaofen Liang(Guangzhou Medical University), Zhihong He(Guangzhou Medical University), Xiaolan Zhu(Guangzhou Medical University), Ruihong Chen(Guangzhou Medical University), Jinman Chen(Guangzhou Medical University)
European Journal of Pharmacology
April 25, 2018
Cited by 92

Abstract


Related Papers

No related papers found

Powered by citation graph analysis